Molecule clue to breast cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have identified a molecule present in most breast cancers which appears to control the growth of cancer cells and could point the way to new treatments. Studies show levels of the molecule, called Brk, are higher in two-thirds of breast cancers but absent in normal breast tissue.
The finding, published in Oncogene, was made by a team at the Institute of Cancer Research. Dr Mark Crompton, leader of the team, said: "With further research, it may be possible to develop drugs that target Brk directly, thus stunting the tumour's growth, without impacting surrounding healthy cells."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments